U.S. General Merchandise and Department Stores Stock News

The Morning Bull - US Market Morning Update Friday, Jul, 10 2026 US stock futures are slightly higher this morning, with E mini S&P 500 contracts up about 0.2%, as investors weigh stubborn borrowing costs and fresh signs of inflation pressure. The US 10 year Treasury yield is holding near 4.58%, meaning mortgages, car loans and business borrowing remain relatively expensive. Oil related price moves are feeding worries that the cost of living could stay higher for longer and keep interest rate...

McDonald's (NYSE:MCD) is planning a major marketing campaign tied to the 2026 FIFA World Cup in North America. The company aims to use World Cup themed promotions to support its value focused menu and drive customer traffic to restaurants. The campaign is intended to coincide with the tournament schedule and broader cultural events around the competition. McDonald's, trading at $276.49, is preparing this World Cup campaign at a time when the stock is down 8.8% year to date and down 5.1%...

Centrus Energy (NYSE:LEU) has secured a $900 million fixed price contract with the U.S. Department of Energy. The agreement covers commercial production of High Assay, Low Enriched Uranium (HALEU) for advanced nuclear fuel. The deal marks a shift for Centrus from a government backed demonstration project to commercial scale enrichment. Centrus Energy moves into this new contract with the stock trading at $173.56 and a mixed recent track record. NYSE:LEU is up 7.0% over the past week and...

On 27 June 2026, Lexicon Pharmaceuticals, Inc. was added to a wide range of Russell indexes, including the Russell 2000, Russell 3000 and multiple related growth and microcap benchmarks. This broad index inclusion can reshape how index-tracking funds, quantitative investors and small-cap growth managers engage with Lexicon, potentially influencing trading volumes and liquidity. We’ll now examine how Lexicon’s broad Russell index inclusion, especially in the Russell 2000, may affect its...

LCI Industries stock is down about 18% year to date, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a discount. This sits against the backdrop of a planned all stock merger with Patrick Industries that will eventually swap each LCI share into Patrick stock. With the share price down 18% so far this year, the current valuation is being set by a market that has turned more cautious on LCI Industries despite a...

Frontdoor, Inc. has expanded its board to nine members and elected Hilla Sferruzza, Executive Vice President and Chief Financial Officer of Meritage Homes, as a director and Audit Committee member, effective June 29, 2026. Her extensive background in finance, accounting and audit oversight, including leadership roles at Meritage Homes and KPMG, could meaningfully shape Frontdoor’s governance and financial risk management. With Sferruzza’s Audit Committee experience now in the mix, we’ll...

Kite Realty Group Trust (NYSE:KRG) was removed from the Russell 2000 Dynamic Index in late June 2026, a change that can affect how index-tracking funds allocate capital to the stock. This index removal brings passive ownership and liquidity into sharper focus for Kite Realty Group, adding a new layer of consideration to its existing retail REIT thesis. We will now examine how Kite Realty Group’s exit from the Russell 2000 Dynamic Index may influence its existing investment narrative and risk...

Nelnet (NNI) is back in focus after reporting quarterly revenue of $353.2 million, a decline of 7.1% year on year. This result missed expectations and coincided with a 6.1% share price decline since the earnings release. See our latest analysis for Nelnet. Zooming out from the latest quarter, Nelnet’s 1-year total shareholder return of 6.2% and 3-year total shareholder return of 41.1% suggest longer term holders have still seen gains, even as near term share price momentum has cooled. If this...

Why AvalonBay Communities Stock Is Back in Focus AvalonBay Communities (AVB) is drawing attention after confirming it will release second quarter 2026 earnings on July 22, 2026, along with ongoing merger plans with Equity Residential. See our latest analysis for AvalonBay Communities. Despite a recent 3.2% drop and a 7 day share price return of a 2.32% decline, AvalonBay Communities still shows a 90 day share price return of 11.59%, while the 1 year total shareholder return is a 2.82%...

In late June 2026, Alto Ingredients, Inc. was added to multiple Russell equity and value indexes, including the Russell 2000, Russell 3000, Russell 2500, and related microcap and value benchmarks, while also partnering on a US$16 million Illinois River infrastructure project to enhance barge-based product transport and storage. This combination of broader index inclusion and investment in river logistics infrastructure highlights Alto Ingredients’ growing institutional visibility and efforts...

In late June 2026, Establishment Labs Holdings Inc. was added to a broad suite of Russell indexes, including the Russell 2000, Russell 3000, and several related growth and small-cap benchmarks, and also appointed veteran healthcare executive and former Cutera CEO Taylor Harris to its Board and key board committees. Harris’s track record in corporate finance, acquisitions, and medtech leadership, combined with the company’s new presence across multiple Russell indexes, could reshape how both...

UFP Industries (UFPI) has been removed from several Russell growth benchmarks, including the Russell 3000 Growth and Russell 2000 Growth indices, a shift that may influence index-linked trading and portfolio positioning. See our latest analysis for UFP Industries. Those index removals come after a period where UFP Industries’ share price has been under pressure, with a 90 day share price return that declined 13.07% and a 1 year total shareholder return that declined 22.32%. The 5 year total...

Big pharma is funding a field it once dismissed. These three psychedelic stocks carry possible clinical catalysts as the healthcare industry turns to alternative medicines.

Billions in prepaid spending flow through this corner of the market every year. Here are three US small-cap stocks positioned to capture it.

Recent commentary from Artisan Partners on slowing growth and a softer outlook for Gartner (IT), together with Russell index rebalancing that moved the stock from large cap to mid cap benchmarks, has sharpened investor focus. See our latest analysis for Gartner. Recent index changes and growth concerns have coincided with weaker momentum in Gartner’s share price. It is down 15.7% on a 30 day basis and 44.0% year to date, while the 1 year total shareholder return has declined 65.8%, pointing...

Why Phibro Animal Health is in focus after Russell index removals Phibro Animal Health (PAHC) has come into focus after being removed from several Russell indices, including the Russell 3000E and Microcap benchmarks, a change that directly affects its index fund exposure. These index removals can prompt mechanical buying or selling by funds that track or reference the affected benchmarks, which can influence trading volumes around the event date rather than reflecting any shift in Phibro...

In late June 2026, Westlake Corporation (NYSE: WLK) was removed from the Russell 1000 Defensive Index and the Russell 1000 Value-Defensive Index, marking its exit from two widely followed benchmarks. This change may alter how quantitatively driven and index-linked investors view the stock’s role in diversified, lower-volatility portfolios. We’ll now examine how Westlake’s removal from these Russell 1000 defensive indices could influence its investment narrative and perceived risk...

Protagonist Therapeutics has already secured FDA approval and a U.S. launch for its psoriasis drug Icotyde, while its polycythemia vera candidate rusfertide is under FDA priority review with an August 2026 action date. This combination of an on-market product and a late-stage asset under priority review is reshaping how investors view Protagonist’s development-to-commercial transition. We’ll now explore how Icotyde’s U.S. launch and the evolving outlook for rusfertide are influencing...

Axogen (AXGN) has been removed from several Russell indexes, including the Russell Microcap Index and Russell 3000E Index. This change can reshape trading patterns as index funds and passive vehicles rebalance their holdings. See our latest analysis for Axogen. Against the backdrop of these index removals, Axogen’s recent trading has been mixed in the very short term but strong over longer periods. The company has a 1-day share price return of 2.04% and a 90-day share price return of 36.48%,...

Transport driven inflation is back in focus after Namibia’s annual rate reached 4.4% in June 2026, with transport costs alone contributing 1.9 percentage points. For transportation sector stocks, that kind of cost pressure can influence fuel bills, fares, freight rates, and ultimately profit margins. It can also shift how investors think about pricing power and resilience when inflation is concentrated in a single category. This article looks at 3 transportation stocks from the screener that...

In late June 2026, Spyre Therapeutics, Inc. (NasdaqGS: SYRE) was removed from several Russell indices, including the Russell 2000 Value, 2500 Value, 3000 Value, 3000E Value, and Small Cap Comp Value benchmarks. This broad index exclusion matters because many passive and benchmark-aware investors adjust their holdings around such reconstitutions, potentially altering trading patterns and liquidity for the stock. Next, we will examine how this broad Russell index removal shapes Spyre...

In late June 2026, BioAge Labs, Inc. (NasdaqGS:BIOA) was added to multiple Russell Growth Benchmark Indexes, including the Russell 2000, Russell 2500, Russell 3000, Russell 3000E, Russell Microcap, and the Russell Small Cap Comp Growth indexes. This broad index inclusion significantly expands BioAge Labs’ visibility among institutional investors and index-tracking funds that follow these Russell Growth benchmarks. Next, we’ll examine how BioAge Labs’ broad Russell Growth index inclusion...

Index changes put Birkenstock Holding in focus Birkenstock Holding (BIRK) has been removed from several Russell growth benchmarks, a shift that can trigger portfolio rebalancing by index-tracking funds and influence short term trading in the stock. See our latest analysis for Birkenstock Holding. Against this backdrop, Birkenstock Holding’s share price has moved to US$45.32, with a 1 day share price return of 2.44% and a 90 day share price return of 19.17%, while the 1 year total shareholder...

In late June 2026, Addus HomeCare Corporation (NasdaqGS: ADUS) was removed from several Russell Growth indices, including the Russell 2000, 2500, 3000, 3000E, and Small Cap Growth benchmarks, following the annual index reconstitution. This broad index removal matters because it can alter demand from index-tracking funds and active managers, potentially reshaping liquidity and the shareholder base for Addus HomeCare. Next, we’ll examine how Addus HomeCare’s broad removal from Russell Growth...